Amniotic membrane properties and current practice of amniotic membrane use in ophthalmology in Slovenia

Cell and Tissue Banking
Tina CirmanMateja Erdani Kreft

Abstract

Amniotic membrane (AM) is the innermost, multilayered part of the placenta. When harvested, processed and stored properly, its properties, stemming from AM biological composition, make it a useful tissue for ophthalmic surgery. AM was shown to have several beneficial effects: it promotes epithelization, has antimicrobial effects, decreases inflammation, fibrosis and neovascularization. Many case reports and case series as well as practical experience (e.g. reconstruction of conjunctival and corneal defects, treatment of corneal ulcers) demonstrated the beneficial effect of AM for different ophthalmological indications. The combination of the above mentioned beneficial effects and reasonable mechanical properties are also the reason why AM is used as a substrate for ex vivo expansion of epithelial progenitor cells. Recently, amnion-derived cells, which also have stem cell characteristics, have been proposed as potential contributors to cell-based treatment of ocular surface disease. However, the use of AM remains one of the least standardized methods in ophthalmic surgery. In this review, the various properties of AM and its current clinical use in ophthalmology in Slovenia are discussed.

References

May 1, 1991·Placenta·Y P TalmiY Zohar
Nov 1, 1991·Cell and Tissue Research·H J WolfD Drenckhahn
Oct 1, 1989·Differentiation; Research in Biological Diversity·J KolegaT T Sun
Apr 1, 1985·American Journal of Obstetrics and Gynecology·D M MainS Strong
Aug 1, 1994·American Journal of Reproductive Immunology : AJRI·P L FidelM D Mitchell
Jan 1, 1994·Biulleten' eksperimental'noĭ biologii i meditsiny·E R MuldashevK S Inchenko
Mar 1, 1997·American Journal of Ophthalmology·S H Lee, S C Tseng
Feb 19, 1998·The Journal of Clinical Endocrinology and Metabolism·R RunićS Guller
Jan 23, 1999·American Journal of Reproductive Immunology : AJRI·S J FortunatoS J Lombardi
May 26, 1999·The British Journal of Ophthalmology·H S Dua, A Azuara-Blanco
Jul 27, 1999·Current Eye Research·M A KurpakusA Kim
Aug 6, 1999·The British Journal of Ophthalmology·A Azuara-BlancoH S Dua
Dec 3, 1999·Klinika oczna·J Markuszewska, P Krzyzanowska
Feb 9, 2000·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·F E KruseH E Völcker
Mar 29, 2000·Survey of Ophthalmology·H S Dua, A Azuara-Blanco
Jul 13, 2000·The New England Journal of Medicine·R J TsaiJ K Chen
Feb 13, 2001·The British Journal of Ophthalmology·P J AddsS Hartley
Feb 28, 2001·Journal of Cataract and Refractive Surgery·M X WangS C Tseng
Mar 23, 2001·American Journal of Obstetrics and Gynecology·M MeinertA Malmström
Jul 24, 2001·The British Journal of Ophthalmology·P J AddsJ K Dart
Aug 17, 2001·Current Opinion in Ophthalmology·K C SippelC S Foster
Feb 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hun Sik KimSun Chang Kim
Mar 27, 2002·The British Journal of Ophthalmology·D MellerS C G Tseng
Jun 22, 2002·Experimental Eye Research·Daniel MellerScheffer C G Tseng

❮ Previous
Next ❯

Citations

Dec 3, 2015·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Danping HuangJing Zhao
Jun 13, 2015·Tissue Engineering. Part B, Reviews·Urška Dragin JermanPeter Veranič
Jul 20, 2016·Cell and Tissue Banking·D HettiarachchiH W W Goonasekera
Jan 5, 2021·Frontiers in Bioengineering and Biotechnology·Antonietta Rosa SiliniOrnella Parolini
May 4, 2021·Frontiers in Bioengineering and Biotechnology·Bretislav LipovýSerhiy Forostyak
Jun 18, 2021·Frontiers in Bioengineering and Biotechnology·Taja Železnik RamutaMateja Erdani Kreft

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
A SolomonF Levi-Schaffer
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
F E Kruse, D Meller
Le Journal médical libanais. The Lebanese medical journal
Naji Waked, Valia El-Kazzi
© 2021 Meta ULC. All rights reserved